Onconic Therapeutics Inc. (KOSDAQ:476060)
16,210
+440 (2.79%)
Nov 20, 2025, 3:30 PM KST
2.79% (1Y)
| Market Cap | 700.93B |
| Revenue (ttm) | 46.65B |
| Net Income (ttm) | 16.75B |
| Shares Out | 44.45M |
| EPS (ttm) | n/a |
| PE Ratio | 41.84 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,742,787 |
| Average Volume | 2,842,598 |
| Open | 15,900 |
| Previous Close | 15,770 |
| Day's Range | 15,500 - 16,620 |
| 52-Week Range | 3,138 - 26,600 |
| Beta | n/a |
| RSI | 56.30 |
| Earnings Date | Nov 11, 2025 |